Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Baker Hughes A | BKR | Nov 20, 2024 | 44.31 | +3.36 |
Ball | BALL | Nov 20, 2024 | 60.42 | +0.85 |
Bank Of America | BAC | Nov 20, 2024 | 46.06 | -0.75 |
Bank Of New York Mellon | BK | Nov 20, 2024 | 77.87 | +0.34 |
Baxter International | BAX | Nov 20, 2024 | 32.63 | +0.34 |
Becton, Dickinson And Co | BDX | Nov 20, 2024 | 222.39 | -0.11 |
Berkshire Hathaway B | BRK-B | Nov 20, 2024 | 468.83 | -0.01 |
Best Buy | BBY | Nov 20, 2024 | 86.77 | -0.29 |
Bio-Techne | TECH | Nov 20, 2024 | 68.72 | +3.54 |
Biogen | BIIB | Nov 20, 2024 | 156.00 | +0.37 |
BlackRock | BLK | Nov 20, 2024 | 1 024.67 | -0.33 |
Blackstone | BX | Nov 20, 2024 | 185.03 | +0.06 |
Boeing | BA | Nov 20, 2024 | 146.08 | +0.33 |
Booking | BKNG | Nov 20, 2024 | 5 016.43 | +0.79 |
BorgWarner | BWA | Nov 20, 2024 | 33.31 | +0.54 |
Boston Properties | BXP | Nov 20, 2024 | 79.56 | +0.18 |
Boston Scientific | BSX | Nov 20, 2024 | 90.17 | -0.18 |
Bristol-Myers Squibb | BMY | Nov 20, 2024 | 57.88 | -0.60 |
Broadcom | AVGO | Nov 20, 2024 | 163.25 | -1.27 |
Broadridge Financial Solutions | BR | Nov 20, 2024 | 225.39 | +0.24 |
Brown & Brown | BRO | Nov 20, 2024 | 109.61 | +0.24 |
Brown Forman B | BF-B | Nov 20, 2024 | 40.30 | +0.20 |
Builders Firstsource | BLDR | Nov 20, 2024 | 174.83 | -2.23 |
Bunge | BG | Nov 20, 2024 | 88.08 | -1.58 |
C.H. Robinson Worldwide | CHRW | Nov 20, 2024 | 109.03 | -0.05 |
Cadence Design Systems | CDNS | Nov 20, 2024 | 304.01 | +1.46 |
Caesars Entertainment | CZR | Nov 20, 2024 | 37.59 | +0.56 |
Camden Property Trust | CPT | Nov 20, 2024 | 120.56 | -0.60 |
Campbell Soup | CPB | Nov 20, 2024 | 43.81 | +0.64 |
Capital One Financial | COF | Nov 20, 2024 | 180.69 | -0.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.